Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology

Epilepsia

Volumn 54, Issue 1, 2013, Pages 199-203

  Mula, Marco ^a,e   Kanner, Andres M ^b   Schmitz, Bettina ^c   Schachter, Steven ^d  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b RUSH MEDICAL COLLEGE   (United States)

^c VIVANTES HOSPITAL   (Germany)

^d HARVARD UNIVERSITY   (United States)

^e University Hospital Maggiore della Carita   (Italy)

Author keywords

Antiepileptic drugs; Depression; Epilepsy; Suicide

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; LAMOTRIGINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ARTICLE; DEPRESSION; DRUG MARKETING; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; HUMAN; IRRITABILITY; MENTAL INSTABILITY; MOOD CHANGE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SIDE EFFECT; SUICIDAL IDEATION; SUICIDE; TREATMENT REFUSAL;

ADVISORY COMMITTEES; ANTICONVULSANTS; EPILEPSY; HUMANS; RISK FACTORS; SUICIDAL IDEATION; SUICIDE;

EID: 84872062135     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03688.x     Document Type: Article

References (45)

1. Andersohn F, Schade R, Willich SN, Garbe E,. (2010) Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 75: 335-340.
2. Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM,. (2010) Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 363: 542-551.
3. Barraclough BM,. (1987) The suicide rate of epilepsy. Acta Psychiatr Scand 76: 339-345.
4. Bell GS, Gaitatzis A, Bell CL, Johnson AL, Sander JW,. (2009) Suicide in people with epilepsy: how great is the risk? Epilepsia 50: 1933-1942.
5. Busco M,. (2008) FDA advisory members agree antiepileptics pose suicidality risk, need for black-box warning. Medscape medical news. Medscape WebMD, New York.
6. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E,. (2007) Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 6: 693-698.
7. Dodrill CB, Troupin AS,. (1977) Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 27: 1023-1028.
8. Ettinger AB,. (2006) Psychotropic effects of antiepileptic drugs. Neurology 67: 1916-1925.
9. FDA. (2008a) Antiepileptic drugs and suicidality. Available at: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf.
10. FDA. (2008b) Information for healthcare professionals: suicidal behavior and ideation and antiepileptic drugs. Available at: http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.html
11. Gelder MG,. (2009) New oxford textbook of psychiatry. Oxford University Press, Oxford.
12. Gibbons R, Hur K, Brown CH, Mann JJ,. (2009) Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 66: 1354-1360.
13. Gibbons RD, Hur K, Brown CH, Mann JJ,. (2010) Gabapentin and suicide attempts. Pharmacoepidemiol Drug Saf 19: 1241-1247.
14. Hara E, Akanuma N, Adachi N, Hara K, Koutroumanidis M,. (2009) Suicide attempts in adult patients with idiopathic generalized epilepsy. Psychiatry Clin Neurosci 63: 225-229.
15. Harris EC, Barraclough B,. (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170: 205-228.
16. Hecimovic H, Salpekar J, Kanner AM, Barry JJ,. (2011) Suicidality and epilepsy: a neuropsychobiological perspective. Epilepsy Behav 22: 77-84.
17. Hesdorffer DC, Kanner AM,. (2009) The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia 50: 978-986.
18. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O,. (2006) Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 59: 35-41.
19. Hesdorffer DC, Berg AT, Kanner AM,. (2010) An update on antiepileptic drugs and suicide: are there definitive answers yet? Epilepsy Curr 10: 137-145.
20. Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, Walczak TS, Beghi E, Brodie MJ, Hauser A,. (2011) Combined analysis of risk factors for SUDEP. Epilepsia 52: 1150-1159.
21. Kanner AM, Wuu J, Faught E, Tatum WOt, Fix A, French JA,. (2003) A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav 4: 548-552.
22. Kanner AM, Soto A, Gross-Kanner H,. (2004) Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 62: 708-713.
23. Kanner AM, Schachter SC, Barry JJ, Hersdorffer DC, Mula M, Trimble M, Hermann B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F,. (2012) Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives. Epilepsy Behav 24: 169-181.
24. Kapur N, Cooper J, King-Hele S, Webb R, Lawlor M, Rodway C, Appleby L,. (2006) The repetition of suicidal behavior: a multicenter cohort study. J Clin Psychiatry 67: 1599-1609.
25. Levinson DF, Devinsky O,. (1999) Psychiatric adverse events during vigabatrin therapy. Neurology 53: 1503-1511.
26. Mula M, Hesdorffer DC,. (2011) Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence. Drug Healthc Patient Saf 3: 15-20.
27. Mula M, Sander JW,. (2007) Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 30: 555-567.
28. Mula M, Sander JW,. (2010) Antiepileptic drugs and suicide risk: could stopping medications pose a greater hazard? Expert Rev Neurother 10: 1775-1776.
29. Mula M, Trimble MR, Lhatoo SD, Sander JW,. (2003a) Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 44: 659-663.
30. Mula M, Trimble MR, Yuen A, Liu RS, Sander JW,. (2003b) Psychiatric adverse events during levetiracetam therapy. Neurology 61: 704-706.
31. Mula M, Trimble MR, Sander JW,. (2007) Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia 48: 2322-2326.
32. Mula M, Hesdorffer DC, Trimble M, Sander JW,. (2009) The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 50: 1072-1076.
33. Mula M, Bell GS, Sander JW,. (2010) Suicidality in epilepsy and possible effects of antiepileptic drugs. Curr Neurol Neurosci Rep 10: 327-332.
34. Olesen JB, Hansen PR, Erdal J, Abildstrom SZ, Weeke P, Fosbol EL, Poulsen HE, Gislason GH,. (2010) Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 19: 518-524.
35. Owens D, Horrocks J, House A,. (2002) Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry 181: 193-199.
36. Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S,. (2010) Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 303: 1401-1409.
37. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ,. (2011) The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168: 1266-1277.
38. Redden L, Pritchett Y, Robieson W, Kovacs X, Garofalo M, Tracy K, Saltarelli M,. (2011) Suicidality and divalproex sodium: analysis of controlled studies in multiple indications. Ann Gen Psychiatry 10: 1.
39. Ring HA, Crellin R, Kirker S, Reynolds EH,. (1993) Vigabatrin and depression. J Neurol Neurosurg Psychiatry 56: 925-928.
40. Robertson MM, Trimble MR,. (1983) Depressive illness in patients with epilepsy: a review. Epilepsia 24 (Suppl. 2): S109-S116.
41. Rodin EA, Rim CS, Kitano H, Lewis R, Rennick PM,. (1976) A comparison of the effectiveness of primidone versus carbamazepine in epileptic outpatients. J Nerv Ment Dis 163: 41-46.
42. Ryvlin P, Cucherat M, Rheims S,. (2011) Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol 10: 961-968.
43. Sadock BJ, Sadock VA, Ruiz P,. (2009) Kaplan and Sadock's comprehensive textbook of psychiatry. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA, London.
44. Trimble MR, Rusch N, Betts T, Crawford PM,. (2000) Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 9: 249-254.
45. VanCott AC, Cramer JA, Copeland LA, Zeber JE, Steinman MA, Dersh JJ, Glickman ME, Mortensen EM, Amuan ME, Pugh MJ,. (2010) Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 8: 4.